Advertisement

Infinity Pharmaceuticals Inc. (Nasdaq: INFI) announced that its research and development collaboration with Purdue Pharmaceutical Products LP has been terminated, but that Purdue will take a $27.5 million equity stake in Infinity. Investors breathed a sigh of relief at the outcome of the restructured contract, buoying Infinity’s stock by more than 7 percent.

Advertisement
Advertisement